Table 4.
Product/dosage | Subjects/study | Methodology | Results | References |
---|---|---|---|---|
Green coffee phenolic extract and oat beta-glucans |
• 60 obese humans • Dose–response randomized parallel trial |
• 72 h record of food intake • Blood samples • Lipid profile determination • Blood pressure measurement • Anthropometry measurement |
• Prevent obesity • Prevent type 2 diabetes • Reduce the cardiovascular risk • Lower total body fat percentage |
[56•] |
Green coffee phenols and beta-glucan |
• 29 humans • Randomized cross-over blind trial |
• Measurement of body weight and BMI • Percentage body fat • Skinfold measurement • Intracellular and extracellular water • Body circumferences measurement • 72 h dietary record |
• Not reduce weight without modifying dietary and physical exercise habits • No change in body composition |
[68] |
Oat beta-glucan supplement |
• 37 obese humans • Randomized double-blind clinical trial |
• Fasting glucose • Insulin • HOMA • C-peptide • HbA1c • ghrelin • Lipid profile leptin • GLP-1 • PYY • Caloric intake • Intestinal microbiota |
• Increase the feeling of satiety • Improve glycemic control • Modify gut profile |
[55•] |
Low molecular weight barley beta-glucan + High molecular weight beta-glucan |
• 24 mice |
• Serum biomarkers • Gut microbiota assessment • The concentration of short chain fatty acid • Measure absorption of fat • Real-time PCR |
• Decrease in serum leptin • Decrease in LDL concentration • Reduction in messenger RNA expression of sterol regulatory element binding protein 1-c |
[69] |
Oat polar lipids | • 20 healthy persons |
• Volunteers drank four liquid-based cereal test drinks • Test variables were assessed while fasting, 3 h after breakfast, and 2 h after a standardized meal |
• Higher quantities of the gut hormones GLP-1 and PYY | [66] |
Beta-glucan enrichment in bread | • 10 healthy adults |
• Blood samples collected • Ghrelin • GLP-1 • PYY • Insulin • Glucose • Glycemic index |
• Higher level of fullness • No change in GLP-1, PYY and ghrelin |
[70] |
Combining beta-glucan and whey protein in energy drinks |
• 10 healthy females • Single blinded cross-over study |
• Adaptive visual analog scale • Blood samples • Glycemic index • Acceptability • Palatability • BMI • Stadiometer |
• Palatability and acceptability were similar • Drinks reduce postprandial blood glucose • Seen no effect on satiety and glycemic index • Natural sources are a good option |
[71] |
Beta-glucan |
• 28 humans • Randomized placebo-controlled crossover trial |
• Subjective appetite • Glucose • Insulin • Ghrelin • Gastric emptying • Peptide tyrosine assessed |
• Effect on postprandial glucose • Effect on insulin • Effect on gastric emptying • No significant effect on appetite and food intake irrespective of the viscosity |
[72] |
Oatmeal |
• 62 Hypercholesterolemic human • Randomized clinical trial |
• Blood samples • Fecal samples • Lipid profile • Microbiota ribosomal RNA amplicon sequencing |
• Lower cholesterol • Positive effect to firmicute phylum |
[61] |
Viscous dietary fiber (beta-glucan) |
• 3877 humans • Randomized control trial |
• Viscous fiber • Ad libitum diet • Body weight • Calorie restriction • BMI • Waist circumference, body fat |
• Improve body weight • Reduce BMI • Reduce waist circumference |
[73] |
Oatmeal | • 5876 children |
• National Health and Nutrition Examination Survey • 2015 USDA Healthy Eating Index • Dietary Research Food and Nutrient Database • Database of food pattern equivalents |
• Children consuming oatmeal have good dietary quality and increase intake of essential nutrients | [74] |
Oatmeal-based diabetes-specific nutritional formulas | • 22 humans with type 2 diabetes |
• Amylin • Cholecystokinin • Ghrelin • Glucagon • Leptin • Peptide-YY |
• Increased peptide YY and glucagon secretion | [75] |
Oat | • 8 rats | • Compare and contrast the effects of oats (cereals) and soybeans (legumes), which are high in distinct types of NSP, on hunger regulation and fat storage in rats | • Short-chain fatty acids (SCFAs) in vivo lower fat mass buildup and manage obesity | [65] |
Oat beta-glucan | • 14 dogs |
• Plasma concentration of peptide YY ghrelin • Serum concentrations of glucose • Total cholesterol lipoprotein • Total tract apparent macronutrient digestibility • Immunoglobulin variables measured |
• Reduce total blood concentration of cholesterol • Reduce the number of red blood cells • Lower concentration of interleukin-4 |
[58] |
Oat beta-glucan |
• 40 participants • Randomized crossover design |
• Fasting blood sample • Apid visco-analyzer • Automatic glucose analyzer • Blood samples |
• 0.4 g addition of oat beta-glucan in instant meal decreases glucose peak rise by 20% | [76] |
Oat beta-glucan |
• 33 normal-weight humans • Randomized double-blind cross-over design |
• Blood samples • Blood glucose determination • Bohin rheometer • Plasma insulin • Plasma GLP-1 |
• Reduces appetite • No reduction is seen in ad libitum eating • Regulates postprandial glycemia • No rise in secretion of plasma GLP-1 |
[57] |
Oat flour | • 106 obese women |
• 24-h dietary recall • Group A consumed snacks while group B consumed a low caloric balanced diet • Anthropometric measurement |
• Reduce central obesity • Reduction in the percentage of body fat • Reduction in metabolic disorders related to obesity |
[60] |
Oat beta-glucan | • 40 mice |
• Hyperlipidemic mouse model • Oleic acid based hepG2 cells model |
• Lipid-lowering effect through AMPK signal pathway | [59] |
Oatmeal breakfast |
• 50 humans • Randomized crossover clinical intervention |
• Fasting blood samples • Visual analog scale • Weight • Height • BMI • High-density lipoprotein • Low-density lipoprotein • Waist circumference • Triglyceride • Nutrition data system • Plasma ghrelin concentration |
• Increase satiety • Increase in cholesterol • No change in glycemic index • Glycemic load decreases • No change in HDL\LDL ratio • No change in triglyceride • No change in liver enzyme • Increase in HDL • Increase in LDL |
[77] |
Liposomes fractionated oat oil | • 19 healthy persons |
• Blood sample analyses • GLP-1 • GLP-2 • CCK • PYY |
• Influence satiety • Delay fat digestion • Modify postprandial plasma lipids • Improve the health of gut |
[64] |
Oat beta-glucan | • 48 subjects | • At least a week apart, subjects ingested isocaloric morning meals with instant oatmeal, old-fashioned oats, or RTEC in random sequence | • The initial viscosity of oats may be essential for appetite reduction | [67] |
Oat cereal beta glucan | • 60 mice |
• HDL cholesterol • Plasma neural peptide Y • Arcuate neural peptide Y • mRNA • Total cholesterol |
• Rise in intestine peptide YY and Plasma peptide YY | [63] |
Oat beta-glucan | • 14 subjects |
• Solubility, viscosity, and molecular weight of beta-glucan were measured • Visual analog scale calculated the satiety |
Promotes satiety • Cholecystokinin release |
[78] |
Oat beta-glucan | • 14 humans | • Volunteers were given a control meal and three cereals with varied beta glucan concentrations and blood samples were taken over 4 h | • An increase in the dose of beta-glucan resulted in greater plasma PYY levels from 2 to 4 h after the test meal | [79] |